Compare Stocks: LZAGY, ABT, ISRG, and MDT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABT Abbott Laboratories	$101.33 +0.0%	$107.21	$81.97 ▼ $135.45	$175.34B	0.59	8.42 million shs	7.77 million shs
ISRG Intuitive Surgical	$405.18	$374.36	$328.57 ▼ $603.88	$143.14B	1.47	2.32 million shs	2.50 million shs
LZAGY Lonza Group	$69.13	$69.43	$58.53 ▼ $74.36	$48.55B	1.09	48,626 shs	73,342 shs
MDT Medtronic	$88.47 -0.2%	$89.69	$73.31 ▼ $106.33	$113.16B	0.56	9.63 million shs	13.05 million shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABT Abbott Laboratories	0.00%	-1.00%	-10.03%	+9.22%	-24.16%
ISRG Intuitive Surgical	0.00%	+3.01%	+8.74%	-0.19%	-8.15%
LZAGY Lonza Group	0.00%	+4.19%	-4.03%	+3.33%	+5.61%
MDT Medtronic	0.00%	-4.04%	-3.08%	+9.23%	-6.23%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABT Abbott Laboratories	$101.33 +0.0%	$107.21	$81.97 ▼ $135.45	$175.34B	0.59	8.42 million shs	7.77 million shs
ISRG Intuitive Surgical	$405.18	$374.36	$328.57 ▼ $603.88	$143.14B	1.47	2.32 million shs	2.50 million shs
LZAGY Lonza Group	$69.13	$69.43	$58.53 ▼ $74.36	$48.55B	1.09	48,626 shs	73,342 shs
MDT Medtronic	$88.47 -0.2%	$89.69	$73.31 ▼ $106.33	$113.16B	0.56	9.63 million shs	13.05 million shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABT Abbott Laboratories	0.00%	-1.00%	-10.03%	+9.22%	-24.16%
ISRG Intuitive Surgical	0.00%	+3.01%	+8.74%	-0.19%	-8.15%
LZAGY Lonza Group	0.00%	+4.19%	-4.03%	+3.33%	+5.61%
MDT Medtronic	0.00%	-4.04%	-3.08%	+9.23%	-6.23%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABT Abbott Laboratories	2.96	Moderate Buy	$119.50	17.93% Upside
ISRG Intuitive Surgical	2.68	Moderate Buy	$508.68	25.54% Upside
LZAGY Lonza Group	2.50	Moderate Buy	N/A	N/A
MDT Medtronic	2.68	Moderate Buy	$103.92	17.47% Upside

Current Analyst Ratings Breakdown

Latest LZAGY, ABT, ISRG, and MDT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/18/2026	ABT Abbott Laboratories	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
9/17/2026	MDT Medtronic	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
9/8/2026	ABT Abbott Laboratories	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$135.00
9/8/2026	ISRG Intuitive Surgical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$469.00
9/4/2026	MDT Medtronic	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
9/3/2026	MDT Medtronic	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$92.00
9/3/2026	MDT Medtronic	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$100.00 ➝ $110.00
9/2/2026	MDT Medtronic	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$115.00
9/2/2026	MDT Medtronic	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$95.00 ➝ $110.00
9/2/2026	MDT Medtronic	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$102.00 ➝ $104.00
9/2/2026	MDT Medtronic	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$86.00 ➝ $99.00

(Data available from 9/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABT Abbott Laboratories	$44.33B	3.96	$6.99 per share	14.49	$30.35 per share	3.34
ISRG Intuitive Surgical	$10.06B	14.22	$9.28 per share	43.67	$50.52 per share	8.02
LZAGY Lonza Group	$7.88B	6.16	$1.99 per share	34.79	$15.79 per share	4.38
MDT Medtronic	$36.36B	3.11	$7.84 per share	11.29	$39.00 per share	2.27

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABT Abbott Laboratories	$6.52B	$3.09	32.79	16.67	1.88	11.65%	17.69%	9.44%	10/21/2026 (Estimated)
ISRG Intuitive Surgical	$2.86B	$8.73	46.41	40.44	3.06	28.45%	16.91%	14.83%	10/20/2026 (Estimated)
LZAGY Lonza Group	$1.15B	N/A	N/A	25.23	1.29	N/A	N/A	N/A	N/A
MDT Medtronic	$4.80B	$4.06	21.79	13.91	2.02	13.93%	14.78%	7.97%	11/17/2026 (Estimated)

Latest LZAGY, ABT, ISRG, and MDT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
10/21/2026	Q3 2026	ABT Abbott Laboratories	$1.42	N/A	N/A	N/A	$12.99 billion	N/A
10/20/2026	Q3 2026	ISRG Intuitive Surgical	$2.64	N/A	N/A	N/A	$2.91 billion	N/A
9/1/2026	Q1 2027	MDT Medtronic	$1.39	$1.45	+$0.06	$1.14	$9.55 billion	$9.76 billion
7/16/2026	Q2 2026	ABT Abbott Laboratories	$1.28	$1.31	+$0.03	$0.53	$12.52 billion	$12.59 billion
7/16/2026	Q2 2026	ISRG Intuitive Surgical	$2.48	$2.80	+$0.32	$2.29	$2.83 billion	$2.89 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABT Abbott Laboratories	$2.52	2.49%	+10.39%	81.55%	54 Years
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
LZAGY Lonza Group	$0.14	0.20%	N/A	N/A	N/A
MDT Medtronic	$2.88	3.26%	+4.13%	70.94%	49 Years

Latest LZAGY, ABT, ISRG, and MDT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
9/17/2026	ABT Abbott Laboratories	quarterly	$0.63	2.47%	10/15/2026	10/15/2026	11/16/2026
8/20/2026	MDT Medtronic	quarterly	$0.72	3.26%	9/25/2026	9/25/2026	10/16/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABT Abbott Laboratories	0.57	1.38	0.97
ISRG Intuitive Surgical	N/A	4.96	3.91
LZAGY Lonza Group	0.42	2.24	1.77
MDT Medtronic	0.50	2.07	1.54

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABT Abbott Laboratories	75.18%
ISRG Intuitive Surgical	83.64%
LZAGY Lonza Group	0.04%
MDT Medtronic	82.06%

Insider Ownership

Company	Insider Ownership
ABT Abbott Laboratories	0.46%
ISRG Intuitive Surgical	0.60%
LZAGY Lonza Group	0.07%
MDT Medtronic	0.27%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABT Abbott Laboratories	115,000	1.73 billion	1.72 billion	Optionable
ISRG Intuitive Surgical	17,021	353.28 million	351.16 million	Optionable
LZAGY Lonza Group	18,686	702.29 million	701.80 million	Not Optionable
MDT Medtronic	95,000	1.28 billion	1.28 billion	Optionable

LZAGY, ABT, ISRG, and MDT Headlines

Recent News About These Companies

Promising Medical Stocks To Consider - September 26th

September 28 at 1:03 AM | americanbankingnews.com

Gilead vs. Medtronic: Which Healthcare Stock Offers the Better Mix of Growth and Income?

September 27 at 11:09 PM | finance.yahoo.com

Pfizer vs. Medtronic: Which Healthcare Turnaround is More Convincing?

September 27 at 8:11 PM | insidermonkey.com

Gilead vs. Medtronic: Which Healthcare Stock Offers the Better Mix of Growth and Income?

September 27 at 8:11 PM | insidermonkey.com

Can Medtronic’s (MDT) Core Units Keep Up With Management’s New Bets?

September 27 at 2:10 PM | insidermonkey.com

Medical Stocks To Add to Your Watchlist - September 27th

September 27 at 2:01 PM | marketbeat.com

Medtronic's High Dividend Yield Gets Little Attention on Wall Street -- Should You Buy the Stock Anyway?

September 27 at 12:48 PM | fool.com

Can Medtronic’s (MDT) Core Units Keep Up With Management’s New Bets?

September 27 at 12:48 PM | finance.yahoo.com

Medtronic's High Dividend Yield Gets Little Attention on Wall Street -- Should You Buy the Stock Anyway?

September 27 at 9:50 AM | fool.com

Why Is Medtronic (MDT) Expanding In Robotics And AI Healthcare?

September 27 at 7:35 AM | finance.yahoo.com

If you are buying individual stocks for the first time in your NISA, is Medtronic (MDT) an option? — A story about a US stock where heart treatment devices grew by 88%

September 26 at 4:34 PM | note.comN

Orchestra BioMed (NASDAQ:OBIO) and Medtronic (NYSE:MDT) Head-To-Head Survey

September 26 at 2:15 AM | americanbankingnews.com

Top Medical Stocks To Watch Now - September 25th

September 25 at 2:00 PM | marketbeat.com

Medtronic PLC's Dividend Analysis

September 25 at 8:37 AM | finance.yahoo.com

Could Medtronic (MDT)’s $700 Million Robotics Bet Unlock its Next Growth Engine?

September 24, 2026 | insidermonkey.com

Could Medtronic (MDT)’s $700 Million Robotics Bet Unlock its Next Growth Engine?

September 24, 2026 | finance.yahoo.com

Medtronic stock heads into the open after a 1.62 percent drop

September 24, 2026 | ad-hoc-news.deA

Temperature Management Systems Market Forecasts Growth from $3.56B (2026) to $4.58B by 2031, Profiling 3M, Asahi-Kasei, GE Healthcare, Dragerwerk & Medtronic

September 24, 2026 | finance.yahoo.com

Medical Robots Market Forecasts Growth from $20.6B (2026) to $41.7B by 2031, Profiling Intuitive Surgical, Stryker, Zimmer Biomet & Medtronic

September 24, 2026 | finance.yahoo.com

Medical Stocks Worth Watching - September 23rd

September 24, 2026 | americanbankingnews.com

Medtronic PLC $MDT Shares Sold by Envestnet Asset Management Inc.

September 24, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

LZAGY, ABT, ISRG, and MDT Company Descriptions

Abbott Laboratories NYSE:ABT

$101.33 +0.04 (+0.04%)

Closing price 09/25/2026 03:59 PM Eastern

Extended Trading

$101.26 -0.07 (-0.07%)

As of 09/25/2026 07:59 PM Eastern

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Intuitive Surgical NASDAQ:ISRG

$405.18 0.00 (0.00%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$405.66 +0.48 (+0.12%)

As of 09/25/2026 07:58 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Lonza Group OTCMKTS:LZAGY

$69.13 0.00 (0.00%)

As of 09/25/2026 03:59 PM Eastern

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.

Medtronic NYSE:MDT

$88.47 -0.17 (-0.20%)

Closing price 09/25/2026 03:59 PM Eastern

Extended Trading

$88.29 -0.18 (-0.20%)

As of 09/25/2026 07:59 PM Eastern

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LZAGY, ABT, ISRG, and MDT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LZAGY, ABT, ISRG, and MDT Earnings

Compare Dividends

Latest LZAGY, ABT, ISRG, and MDT Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LZAGY, ABT, ISRG, and MDT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

LZAGY, ABT, ISRG, and MDT Company Descriptions

Abbott Laboratories NYSE:ABT

Intuitive Surgical NASDAQ:ISRG

Lonza Group OTCMKTS:LZAGY

Medtronic NYSE:MDT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools